Skip to content

Interest Paid at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$90K-2.2%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$20.32M-12.7%
Royalty Pharma logo
Royalty PharmaRPRX
$173.53M+25.0%
AbbVie logo
AbbVieABBV
$750.5M+6.8%
Revvity logo
RevvityRVTY
$21.55M-5.4%
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$11.52B+402%
Enterprise value$11.44B+418%
P/S18.5×+14.3×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Arrowhead Research’s 10-K, filed November 25, 2025, on SEC EDGAR. View the filing →

Ask your AI about Arrowhead Research's interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arrowhead Research's interest paid?
Arrowhead Research (ARWR) reported interest paid of $4.75K in Q3 2025.
What does interest paid mean?
The actual amount of cash paid to lenders for interest on debt.
How do you interpret interest paid?
An increase suggests higher debt service requirements or rising interest rates, while a decrease may indicate debt repayment or refinancing at lower rates.
How does interest paid compare across companies?
Standard disclosure across all public companies; peers in biotech often show low interest paid if they rely on equity financing rather than debt.